来自MSN21 天
San Diego biotech Halozyme makes $2.1B bid for German drugmaker
Update: Halozyme Therapeutics announced Friday morning at 5:35 a.m. that it has withdrawn its proposed acquisition of Evotec. This is a developing story. Halozyme Therapeutics, a San Diego-based ...
pharmaphorum1 天
Halozyme abandons its €2bn pursuit of Evotec
US biotech Halozyme Therapeutics has withdrawn its offer to acquire Evotec, saying that the German company had been "unwilling to engage with us to explore a potential combination." Halozyme made ...